Phase II Study Of Roferon and Accutane For Patients With T-Cell Malignancies
Clinical trial NCT00038376 · COMPLETED
Trial details
- NCT number
- NCT00038376
- Sponsor
- M.D. Anderson Cancer Center
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 1990-05-08
- Primary completion
- 2005-06-30
- Enrollment
- 56
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.